THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

Eric J. Topol, Robert M. Califf, Barry S. George et al. · New England Journal of Medicine · 1987 · 945 citations

Medicine, Cardiology, Internal Medicine +16

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, M Bory, D Collen et al. · The Lancet · 1985 · 752 citations

Medicine, Cardiology, Pharmacology +10

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Medicine, Cardiology, Internal Medicine +11

LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY

GRUPPOITALIANOPERLOSTUDIODELL · The Lancet · 1987 · 558 citations

Medicine, Cardiology, Internal Medicine +13